SCHEMBL7076248

SCHEMBL7076248

COc1ccc(-c2sccc2C(=O)O)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.54
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
PTGS2 P35354 2/20 0.50
ALDH1A1 P00352 4/20 0.49
KDM4E B2RXH2 3/20 0.49
HPGD P15428 2/20 0.49
POLB P06746 2/20 0.49
GAA P10253 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
MAPT P10636 1/20 0.46
RECQL P46063 1/20 0.46
PTPN1 P18031 1/20 0.45
CA12 O43570 1/20 0.44
CA3 P07451 1/20 0.44
CA4 P22748 1/20 0.44
CA5A P35218 1/20 0.44
CA7 P43166 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29790204 0.83 FYN (0.38) SMN1; SMN2NPC1RAB9APTGS2ALDH1A1
SCHEMBL7078258 0.81 DHODH (0.54) ALDH1A1KDM4EHPGDPOLBMAPT
SCHEMBL1340970 0.80 MEN1 (0.49) SMN1; SMN2NPC1RAB9APTGS2ALDH1A1
SCHEMBL15546178 0.78 KDM4E (0.51) SMN1; SMN2PTGS2ALDH1A1KDM4EHPGD
SCHEMBL3316024 0.77 KMT2A (0.50) SMN1; SMN2PTGS2ALDH1A1KDM4EHPGD
SCHEMBL14398910 0.77 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9AALDH1A1KDM4E
SCHEMBL15276735 0.77 MEN1 (0.50) SMN1; SMN2ALDH1A1KDM4EHPGDPOLB
SCHEMBL1340677 0.77 PTGS1 (0.53) PTGS2ALDH1A1KDM4EHPGDCA1
SCHEMBL15775800 0.77 ACMSD (0.46) RAB9AKDM4EPOLBRXFP1MAPT
SCHEMBL982263 0.76 SMN1; SMN2 (0.54) SMN1; SMN2NPC1RAB9APTGS2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003051368-A1 N-AROYL CYCLIC AMINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 2003-06-26 WO disclosed